The latest cancer drugs news
Browsing: Cancer Drug News
ESMO 2018: Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of…
ESMO 2018: Olaparib maintenance extends PFS by estimated 3 years in advanced ovarian cancer
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to…
ESMO 2018: Drugs for treating breast cancer in women are effective and well tolerated in men
There is growing evidence that drugs approved for the treatment of breast cancer in women…
ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…
Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with high-risk stage three melanoma
Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with…
Anti-psychotic drug could treat aggressive breast cancer
A commonly-used anti-psychotic drug could also be effective against triple negative breast cancer, the form…
Breast cancer drug could be used to treat life-threatening leukaemia
A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia,…
Health-related quality of life overlooked in cancer drug studies
A McMaster University-led review and analysis of randomised clinical trials is questioning whether interventions which…
New approach on the use of big data in clinical decision support
A new computational approach that allows the identification of molecular alterations associated with prognosis and…
CHMP announched positive opinion for brigatinib as treatment of ALK positive NSCLC in patients previously treated with crizotinib
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive…